recall
saveApotex Corp. recall (Cls II)
July 2, 2025updated 6mo ago
community read0 votes
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-3 — Reason: Lack of Assurance of Sterility — Status: Ongoing
view source ↗Data sources
last refreshed 21m ago
Found something off?
same company · ±60 days · 5
- recallApotex Corp. recall (Cls II)Jul 2, 2025
- recallApotex Corp. recall (Cls II)Jul 2, 2025
- approvalTRAZODONE HYDROCHLORIDE: TRAZODONE HYDROCHLORIDE — FDA approvalJun 24, 2025
- approvalTRAZODONE HYDROCHLORIDE: TRAZODONE HYDROCHLORIDE — FDA approvalJun 24, 2025
- recallApotex Corp. recall (Cls II)Jun 11, 2025
🐶 often sniffed alongside
top 8- tagRecall17 co-mentions · 7 sources
- drugBRIMONIDINE TARTRATE7 co-mentions · 3 sources
- drugIstalol7 co-mentions · 3 sources
- drugbrimonidine7 co-mentions · 3 sources
- drugBetimol7 co-mentions · 3 sources
- drugCusimolol7 co-mentions · 3 sources
- drugtimolol7 co-mentions · 3 sources
- drugCOMBIGAN7 co-mentions · 3 sources
comments(0)
5-min edit window · permanent after that